SUN PHARMACEUTICAL INDUSTRIES LTD.-COMPANY INSIGHT - TF Market Research

SUN PHARMACEUTICAL INDUSTRIES LTD.-COMPANY INSIGHT

56 pages — Published Mar 18, 2008
Price $82,225.00  |  Buy this Report Now
  
This report is also available for purchase on a per-page basis.

About This Report

  
Brief Excerpt:
...Sun Pharmaceutical Industries Ltd., is a specialty pharmaceutical company that manufactures and markets pharmaceutical formulations and generics. The company is a leader in niche therapy areas of psychiatry, neurology, cardiology, diabetology, gastroenterology, and orthopedics. It was established in ####. Sun Pharma is committed to world class research that develops innovative medicines. The company's first research center, Sun Pharma Advanced Research Center (SPARC) was set up in #### and was instrumental for the quick growth of Sun Pharma. In the first phase, a drug discovery initiative is taking shape in # specific therapy areas, and across four drug delivery system platforms. Its R&D priority areas include: Reverse Engineering, process development and NDDS. Sun Pharma manufactures a range of APIs including complex actives like anticancer, ster oids, peptides and hormones are manufactured in dedicated areas that follow international norms for systems and processes....
  
Source:
LIFE SCIENCE ANALYTICS
Author:
HARINATHA, G.
Company
SUN PHARMACEUTICAL INDUSTRIES LTD
Geographic Regions
ASIA , INDIA , SOUTHERN ASIA
Non-Billable Page Numbers
2
Format:
PDF Adobe Acrobat
Sections
TitleStarting PageNumber of Pages
Company Information11
Sun Pharmaceutical Industries Ltd. [NonUS -- Symbol : SUNPHARMA (NSE (India))]11
Formation Date: 198311
Business Summary11
Milestone31
Date Category31
Product Glance31
Diseasehub Classification32
Product Summary41
Partner45
Condition Treated81
Product Details81
1. Mirtaz (mirtazapine) Central Description Mirtaz81
Therapeutic Drug Class Current Trial Trial Details Last Updated81
2. Nitrosun (nitrazepam) Central Description Nitrosun91
Therapeutic Seizures Current Trial M Trial Details Presently it is Last Updated 12/28/2006 4. Flosef (fluorometholone) Auto91
Therapeutic91
Drug Class Antihistaminic Current Trial M Trial Details Presently it Last Updated 11/22/2006 8. Suminat (sumatriptan) Centra101
Therapeutic Drug Class101
Current Trial M Trial Details Presently it is Last Updated 11/28/2006 13. Restofos (alendronic acid) Women's Health Descript111
Therapeutic Anesthesia Current Trial M Trial Details Presently it is Last Updated 5/25/2007 16. Fendrop (fentanyl citrate)111
Therapeutic Current Trial Trial Details Last Updated121
23. Glypride (glimepiride) Description Glypride131
Therapeutic Drug Class Current Trial Trial Details131
Therapeutic141
Drug Class Antiinflammatory Current Trial M Trial Details Presently it is Last Updated 11/22/2006 34. Azrol Inhaler (salmeter151
Therapeutic Vertigo Current Trial M Trial Details Presently it is Last Updated 11/22/2006 36. Bronkonat (salbutamol) Respir151
Therapeutic Drug Class Current Trial161
Trial Details Presently it is available in Last Updated 5/7/2007 45. Angizem (diltiazem hydrochloride) Cardiovascular and De171
Therapeutic Cardiovascular Current Trial M Trial Details Presently it Last Updated 9/11/2007 49. Cardivas (carvedilol) Card171
Therapeutic Drug Class171
Current Trial M Trial Details Presently it Last Updated 5/7/2007 50. Clopilet (clopidogrel) Cardiovascular Description Clopi181
Therapeutic Acute Current Trial M Trial Details Presently it Last Updated 9/11/2007 51. Duracard (doxazosin) Cardiovascular181
Therapeutic Drug Class Current Trial Trial Details Last Updated181
55. Monotrate (isosorbide mononitrate) Cardiovascular and Description Monotrate contains191
Therapeutic201
Drug Class Antiemetics Current Trial M Trial Details Presently Last Updated 11/22/2006 66. Octride (octreotide) Digestive De211
Therapeutic Diarrhea Current Trial M Trial Details Presently it is Last Updated 9/11/2007 67. Pantocid (pantoprazole) Diges211
Therapeutic Drug Class Current Trial Trial Details211
Last Updated 2/4/2008 68. Sompraz (esomeprazole) Digestive System Description Sompraz211
Therapeutic Drug Class Current Trial211
Trial Details Presently it is available Last Updated 11/22/2006 70. Ursocol (ursodeoxycholic acid) Digestive System Descript221
Therapeutic Gallstones Current Trial M Trial Details Presently it Last Updated 11/22/2006 71. Caberlin (cabergoline) Women'221
Therapeutic Current Trial M Trial Details Presently Last Updated 9/11/2007 72. Gynazol (danazol) Women's Description Gynazo221
Therapeutic Current Trial M Trial Details Presently Last Updated 6/4/2007 73. Letoval (letrozole) Cancer Description Letova221
Therapeutic Current Trial Trial Details221
Last Updated 10/17/2007 75. Mifeprin (mifepristone) Women's Description Mifeprin231
Therapeutic Pregnancy Current Trial M Trial Details Presently it is Last Updated 9/11/2007 76. Susten (progesterone) Women'231
Therapeutic Labor and Current Trial M Trial Details Presently it Last Updated 5/7/2007 78. Zitotec (misoprostol) Women's De231
Therapeutic Labor and Current Trial M Trial Details Presently it is Last Updated 6/5/2007 79. Rolsical SG (calcitriol) Kidn231
Therapeutic Peripheral Current Trial M Trial Details Presently it is Last Updated 11/23/2006 83. Cognitol 5 (vinpocetine) C241
Therapeutic Parkinson Disease Current Trial M Trial Details Presently it is Last Updated 10/11/2007 85. Encorate (sodium val241
Therapeutic Epilepsy Current Trial M Trial Details Presently it is Last Updated 9/11/2007 86. Flexital (oxpentifylline) Car251
Therapeutic Epilepsy Drug Class Current Trial M Trial Details Presently Last Updated 88. Liofen (baclofen) Musculo Descript251
Therapeutic Spasm Current Trial M Trial Details Presently Last Updated 1/18/2008 89. Nodict (naltrexone) Substance Descript251
Therapeutic Drug Class Current Trial M Trial Details Last Updated 91. Rilutor (riluzole)251
Description261
Therapeutic Amyotrophic Current Trial M Trial Details Presently it is Last Updated 11/23/2006 92. Rivamer (rivastigmine) Ce261
Therapeutic Alzheimer Current Trial M Trial Details Presently Last Updated 5/24/2007 93. Ropark (ropinirole) Central Descri261
Therapeutic Current Trial261
Trial Details Presently it is available Last Updated 4/30/2007 97. Oncobleo (bleomycin sulphate) Cancer Description Oncobleo271
Therapeutic Breast Cancer Drug Class Natural Current Trial M Trial Details Presently it is Last Updated 6/6/2007 102.Oncotr271
Description281
Therapeutic Sjogren Current Trial M Trial Details Presently Last Updated 9/17/2007 105.Imalek (imatinib) Cancer Description281
Therapeutic Current Trial Trial Details Last Updated291
112.Lobazam (clobazam) Central Description Lobazam301
Therapeutic Dry Eyes Current Trial M Trial Details Presently it is Last Updated 4/30/2007 120.Facidase (hyaluronidase) Cent311
Therapeutic311
Drug Class Antiinflammatory Current Trial M Trial Details Presently it is available in the Last Updated 9/11/2007 123.Ketori321
Description331
Therapeutic Myasthenia Current Trial M Trial Details Presently it Last Updated 11/23/2006 135.Topirol (topiramate) Central341
Therapeutic Drug Class Current Trial Trial Details341
Last Updated 11/6/2007 138.Lupride depot (leuprolide acetate) Cancer Description Lupride is a long-acting341
Therapeutic Current Trial Trial Details352
Last Updated 10/17/2007 139.Lipodox (liposomal doxorubicin hydrochloride) Cancer Description Lipodox (liposomal doxorubicin)351
Therapeutic Drug Class Current Trial Trial Details361
Last Updated 3/14/2007 143.Sibutrex (sibutramine hydrochloride) Metabolic/Endocrinology Description Sibutrex contains sibutr361
Therapeutic Appetite Current Trial M Trial Details Presently it is Last Updated 12/19/2006 144.Graniset (granisetron) Diges361
Last Updated 1/17/2008 145.Zofer (ondansetron) Digestive Description Zofer361
Therapeutic Asthma Current Trial M Trial Details Presently Last Updated 11/24/2006 147.Ezentia (ezetimibe) Description Ezen361
Therapeutic Drug Class Current Trial Trial Details Last Updated361
148.Korandil (nicorandil) Cardiovascular Description Korandil371
Therapeutic Angina Current Trial M Trial Details Presently it Last Updated 3/12/2007 149.Ibsinorm (tegaserod) Digestive Des371
Therapeutic Drug Class371
Current Trial M Trial Details Presently it Last Updated 2/1/2008 154.Modalert (modafinil) Central Description Modalert381
Therapeutic Drug Class Current Trial Trial Details391
Last Updated 11/24/2006 161.Dicorate (divalproex sodium) Central Nervous Description Dicorate contains391
Therapeutic Seizures Current Trial M Trial Details Presently it Last Updated 11/24/2006 162.Arpizol (aripiprazole) Central391
Therapeutic Intraocular Current Trial M Trial Details Presently it is Last Updated 2/28/2007 168.Anofer (sodium docusate) D401
Therapeutic Drug Class401
Current Trial M Trial Details Last Updated 170.Phenytoin ER Description411
Therapeutic Drug Class Current Trial Trial Details411
Last Updated Partnering Details412
171.Metoprolol XL Description411
Therapeutic Drug Class Current Trial M Trial Details Last Updated 172.Oxcarbazepine Central Description411
173.Nimodipine Description421
Therapeutic Current Trial Trial Details424
174.Pantoprazole Sodium Delayed Release Tablets Digestive System Description Pantoprazole Sodium Delayed Release421
175.Rivastigmine tartrate Central421
Description431
Last Updated 10/26/2007 176.Carbidopa with Levodopa Central Nervous Description Carbidopa with431
Last Updated 177.Galantamine Description431
Therapeutic Drug Class Current Trial Trial Details432
Last Updated 1/28/2008 178.Divalproex sodium Delayed release Tablets Central Nervous System Description Divalproex sodium is431
Therapeutic Current Trial431
Trial Details441
Last Updated 179.SUN 1334 H Description441
Last Updated 180.SUN 461 Description441
Therapeutic Drug Class Current Trial Trial Details Last Updated 181.SUN 44 Description441
Last Updated 182.SUN 09 Description441
Last Updated 3/22/2007 183.Rofact (rofecoxib) Musculo- Description Rofact is451
Last Updated 11/28/2006 184.Tobramycin and dexamethasone opthalmic solution Ophthalmology and Optometry Description Tobramyc451
Therapeutic Eye Current Trial NA Trial Details Last Updated 185.Baclofen GRS Description451
Therapeutic Drug Class Current Trial Trial Details Last Updated451
Recent Financings461
Corporate Partners461
Deal Category: Miscellaneous Date461
Deal Value (in $ MM)462
Date471
Partner471
Deal Category: Product Date471
Management Profile481
Dilip S Shanghvi -- Chairman and Managing Director481
Sudhir V Valia -- Whole time Director481
Sailesh T Desai -- Wholetime Director481
S Mohanchand Dadha -- Director481
Hasmukh S Shah -- Director481
Keki Mistry -- Director481
Recent Updates491
Company Announcements491
2/9/2006 -- Board Clears demerger Proposal491
8/10/2005 -- Sun Pharma to buy manufacturing site in Hungary491
5/12/2005 -- Sun Pharma to donate hostel for medical college491
12/7/2004 -- President to inaugurate Sun Pharma's research center491
8/6/2004 -- Sun Pharma: Fire in Unit 1 at Panoli491
6/21/2004 -- Fire put out at Sun Pharma's corporate offices501
2/2/2004 -- Mr. Ashwin Dani joins Sun Pharma board501
2/14/2003 -- DMF approval for Metaprolol tartrate received501
9/10/2002 -- Biostudy volunteer in hospital with pneumonia501
8/29/2002 -- Mr Keki Mistry joins Sun Pharma's Board of directors501
3/28/2002 -- Sun Pharma's new plant at Dadra commences operations501
2/10/2001 -- Board to meet to consider merger of Pradeep Drugs501
10/25/1999 -- Sun Pharma to set up new research campus in Chennai511
Deals & Alliances511
9/23/2004 -- Sun Pharma to buy 3 US brands for $5.4 mill Entry in brand market in North America511
Financials511
12/3/2004 -- Sun Pharma launches additional US$75mill FCCB511
11/27/2004 -- Sun Pharma completes $275 mill FCCB511
11/20/2004 -- Information on additional Launch of FCCB for US$50 Million Issue by the Company511
11/18/2004 -- Sun Pharma launches $225 mill FCCB Issue521
4/8/2004 -- Sun Pharma to raise $350mill, EGM announced521
12/20/2002 -- EGM clears resolutions for split, buyback521
6/28/2002 -- Sun Pharma announces Bonus Preference Shares carrying coupon of 6% in ratio of 4 shares of Rs 1/- each per 1 equ521
2/1/2000 -- Sun Pharma announces bonus: 2 shares for 1 held521
Intellectual Property521
1/2/2008 -- Orion Comments on New Challenge by Sun Pharmaceutical Industries Ltd., India, of521
Orion's U.S. Patent No. 5,446,194 Covering Its Proprietary Drug Stalevo in the United States531
12/6/2007 -- Sun Pharma Announces Settlement of Litigation Over Generic Exelon531
Mergers & Acquisitions531
5/21/2007 -- Sun Pharma to acquire Taro Pharma in a USD 454 million deal531
2/9/2006 -- Sun Pharma Announces Q&A demerger531
12/23/2005 -- Sun Pharma closes Able Labs acquisition in the US531
7/31/2004 -- Sun Pharma announces swap ratio for Phlox Pharma merger531
3/9/2004 -- Clarification on news items regarding acquisition of HAL541
2/26/2001 -- Sun Pharma board announces 1:500 ratio for PDC541
11/26/2000 -- Sun Pharma-Milmet Labs merger541
4/8/1999 -- BIFR Okays GLOL merger541
Product Update541
1/30/2008 -- Sun Pharma Launches Generic Protonix Tablets541
10/10/2007 -- Sun Pharma announces USFDA approval to market generic Trileptal Tablets541
Regulatory551
10/23/2007 -- Sun Pharma announces USFDA approval to market generic Exelon Capsules551
9/11/2007 -- Sun Pharma Announces US FDA Approval to Market Generic Protonix Tablets551
8/30/2007 -- Sun Pharma Announces USFDA tentative approval to market generic Razadyne Tablets551
8/25/2007 -- Sun Pharma announces USFDA approval to market generic Sinemet CR Tablets551
8/18/2007 -- Sun Pharma announces FDA approval to market generic Octreotide injection551
12/15/2006 -- Caraco Pharmaceutical Laboratories Ltd. to Market Extended Phenytoin Sodium Capsules, USP 100mg551
10/20/2006 -- Sun Pharma's lead molecule enters Phase II in the US561
6/13/2006 -- Sun Pharma gets initial U.S. nod for ondansetron tabs561
5/26/2004 -- Sun Pharma's bulk active and tablet manufacturing factories are cleared by USFDA561

Table Of Contents

TF Market Research® reports contain in-depth primary research and statistics, market trends, forecasts, segment analysis and much more from over 100 top consulting, market research and business publishing sources. The service is updated daily.

About the Author


Cite this Report

  
MLA:
TF Market Research. "SUN PHARMACEUTICAL INDUSTRIES LTD.-COMPANY INSIGHT" Mar 18, 2008. Alacra Store. May 20, 2013. <http://www.alacrastore.com/storecontent/markintel/LIFE_SCIENCE_ANALYTICS-50183149>
  
APA:
TF Market Research. (2008). SUN PHARMACEUTICAL INDUSTRIES LTD.-COMPANY INSIGHT Mar 18, 2008. New York, NY: Alacra Store. Retrieved May 20, 2013 from <http://www.alacrastore.com/storecontent/markintel/LIFE_SCIENCE_ANALYTICS-50183149>
  
$82,225.00
$  £  €
Have a Question?
Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.
More Research
Search all our Market Research from one place.